Riferimenti bibliografici

1. Thomas E. Van Dyke Corneliu Sima; “Understanding resolution of inflammation in periodontal diseases: Is chronic inflammatory periodontitis a failure to resolve?” Peridontology 2000 February 2019; 85 205-213.
2. Danica C.Slavish, Jennifer E.Graham-EngelandaJoshua M.Smyth, Christopher G.Engeland, “Salivary markers of inflammation in response to acute stress” Brain, Behavior, and Immunity Volume 44, February 2015: 253-269.
3. Hummel J, Phillips KE, Holt B, Hayes C. Oral health: an essential component of primary care. Seattle, WA: Qualis Health; June 2015.
4. Jeffcoat MK, Jeffcoat RL, Gladowski PA et al. Impact of periodontal therapy on general health evidence from insurance data for five systemic conditions. Am J Prev Med. 2014;47(2):116-174.
5. Schenkein, HA, Loos BG. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Clin Periodontol. 2013; 40 (suppl. 14):S51-S69.
6. Mealy BL, Rose LF. Diabetes mellitus and inflammatory periodontal diseases: current opinion in endocrinology. Diabetes and Obesity 15:135-141, April 2008.
7. Sheiham A, Watt RG. The common risk factor approach: a rational basis for promoting oral health. Community Dent Oral Epidemiol. 2000;28(6):399-406.
8. McKernan SC, Kuthy RA, Reynolds JC et al. 2018. Medical-dental integration in public health settings: an environmental scan. Iowa City, IA: University of Iowa Public Policy Center.
9. Bauer UE, Briss PA, Goodman RA, Bowman BA. Prevention of chronic disease in the 21st Century: elimination of the leading preventable causes of premature death and disability in the USA. The Lancet, Volume 384, No. 9937, p 45-52, 5 July 2014.
10 Toyoko Morita Bsc, Yoko Ogawa DDS, Koji Takada Msc, “Association Between Periodontal Disease and Metabolic Syndrome” Journal of Public Health Dentistry Volume 69, Issue 4 Fall 2009: 248-253.
11. KeikoWatanabe, Yale D.Cho. “Periodontal disease and metabolic syndrome: A qualitative critical review of their association” Archives of Oral Biology Volume 59, Issue 8, August 2014: 855-870.
12. Anuj Sharma, A.R. Pradeep, Arjun Raju P. “Association Between Chronic Periodontitis and Vasculogenic Erectile Dysfunction” Journal of Periodontology 2011 Volume 82 issue 12; 1665-1669.
13. Beckerman M. Cellular Signaling in Health and Disease. Springer-Verlag New York 2009.
14. Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5-17.
15. Dinarello CA. Anti-inflammatory Agents: Present and Future. Cell. 2010;140(6):935-50.
16. Kim WJ. Cellular signaling in tissue regeneration. Yonsei Med J. 2000;41(6):692-703
17. Randelli, F.; Menon, A.; Giai Via, A.; Mazzoleni, M.G.; Sciancalepore, F.; Brioschi, M.; Gagliano, N. Effect of a Collagen-Based Compound on Morpho-Functional Properties of Cultured HumanTenocytes. Cells 2018, 7, 246.
18. Petrovsky N., Leonard C. Harrison “The Chronobiology of Human Cytokine Production” International Review of Immunology 1998, 16: 635-649
19. Coomes EA, Haghbayan H. Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev Med Virol. 2020;30(6):1-9. doi:10.1002/rmv.2141
20. Conti P, Ronconi G, Caraffa A et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):1.
21. Narazaki M, Kishimoto T. The Two-Faced Cytokine IL-6 in Host Defense and Diseases. Int J Mol Sci. 2018;19(11):3528.
22. Naruishi K, Nagata T. Biological effects of interleukin-6 on Gingival Fibroblasts: Cytokine regulation in periodontitis. J Cell Physiol. 2018 Sep;233(9):6393-6400.
23. Kobayashi T, Okada M, Ito S et al. Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis. J Periodontol. 2014;85(1):57–67.
24. Kobayashi T, Ito S, Kobayashi D et al. Interleukin-6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors. Clin Exp Dent Res. 2015;1(2):63–73.
25. Azuma MM, Samuel RO, Gomes-Filho JE, Dezan-Junior E, Cintra LT. The role of IL-6 on apical periodontitis: a systematic review. Int Endod J. 2014 Jul;47(7):615-21.
26. Söder B, Jin LJ, Klinge B, Söder PÖ. 2007. Periodontitis and premature death: a 16-year longitudinal study in a Swedish urban population. J Periodontal Res. 42(4):361–366.
27. Sanz M, Marco del Castillo A, Jepsen S, Gonzalez-Juanatey JR, D’Aiuto F,Bouchard P, Chapple I, Dietrich T, Gotsman I, Graziani F, et al. 2020. Periodontitis and cardiovascular diseases: consensus report. J Clin Periodontol. 47(3):268–288.
28. Graziani F, Gennai S, Solini A, Petrini M. 2018. A systematic review and metaanalysis of epidemiologic observational evidence on the effect of periodontitis on diabetes—an update of the EFP-AAP review. J Clin Periodontol. 45(2):167–187.
29. Solini A, Suvan J, Santini E, Gennai S, Seghieri M, Masi S, Petrini M, D’Aiuto F, Graziani F. 2019. Periodontitis affects glucoregulatory hormones in severely obese individuals. Int J Obes. 43(5):1125–1129.
30. Monsarrat P, Blaizot A, Kémoun P, Ravaud P, Nabet C, Sixou M, Vergnes JN. 2016. Clinical research activity in periodontal medicine: a systematic mapping of trial registers. J Clin Periodontol. 43(5):390–400.
31. Price W A. 1816 The Pathology of Dental Infections and Its Relation to General Diseases University of Toronto – Henry Abbott Dentistry Library.
32. Konig MF, Abusleme L, Reinholdt J, Palmer RJ, Sampson K, Teles RP, Nigrovic PA, Rosen A, Sokolove J, Giles JT, Moutsopoulos NM, Andrade F. Aggregatibacter Actinomycetemcomitans-Induced Hypercitrullination Links Periodontal Infection to Autoimmunity in Rheumatoid Arthritis [abstract].Arthritis Rheumatol.2016; 68 (suppl 10). https://acrabstracts.org/abstract/aggregatibacter-actinomycetemcomitans-induced-hypercitrullination-links-periodontal-infection-to-autoimmunity-in-rheumatoid-arthritis/. Accessed February 14, 2021.